Skip to main content
Premium Trial:

Request an Annual Quote

Five Prime Therapeutics Subscribes to Gene Logic s BioExpress

NEW YORK, July 7 - Gene Logic said today that Five Prime Therapeutics has purchased a subscription to its BioExpress Custom Suite, a subset of gene expression data from the company's GeneExpress database.

 

Five Prime will use the data as part of its therapeutics discovery efforts. Gene Logic will also generate additional gene expression data using proprietary microarrays developed by Five Prime and will integrate the resulting data into the dataset.

 

Financial details of the multiyear subscription agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more